)
The European Health Summit discusses investment in cardiovascular health
Strategic Public Private Partnerships are required to tackle cardiovascular disease more effectively.
Strategic Public Private Partnerships are required to tackle cardiovascular disease more effectively.
We are pleased to announce that the International Pharmaceutical Federation (FIP) has joined the Council for Heart Health as an Associate Member.
The International Pharmaceutical Federation (FIP) today launched a new practice support handbook for pharmacists on cardiovascular disease (CVD) services.
The World Heart Federation has launched an updated Cholesterol Roadmap 2022 which provides a framework for evidence-based policy solutions for the prevention and management of cholesterol very (...)
The G20 Health & Development Partnership (G20HDP) has this month issued a Call to Action to wealthy countries to do more to tackle cardiovascular disease around the world.
The last 18 months have been devastating for the global health community. The fight against the COVID-19 pandemic has left behind other critical health challenges that now risk triggering a (...)
The Declaration of the G20 Health Ministers (5-6 September 2021) acknowledges[1] “[...]that non-communicable diseases such as cancer, cardiovascular disease (...)